InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Dalgleish Scott, Chief Financial Officer. Officer active across 1 company, notably Oncology Institute, Inc.. In total, 2 reports have been published. History available since 12 November 2021. The latest transaction was filed on 21 March 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations2 total
32,092 shares0Common stockSEC:0001628280-22-007103:0
47,566 shares0Common StockSEC:0001104659-21-140226:0
2 of 2 declarations
About Dalgleish Scott
Scott Dalgleish serves as the Chief Financial Officer of Oncology Institute, Inc. In this role, he is responsible for managing the company's finances, including budgeting and financial analysis.
